Travere Therapeutics Inc (TVTX)

MATERIALS: CHEMICALS
SIC: PHARMACEUTICAL PREPARATIONS

3611 VALLEY CENTRE DR SAN DIEGO, CA 92130

Retrophin, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orphan drugs for the treatment of rare and life-threatening diseases. The company develops treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases. Its products include RE-021, a small molecule angiotensin receptor blocker and selective endothelin receptor antagonist for the treatment of FSGS; and RE-024, a drug that restores the disruption in the biochemical Coenzyme A pathway caused by the non-functioning PANK2 encoded enzyme.

Data as of 2021-02-27 10:34:43 -0500
Market Cap1.573 Billion Shares Outstanding51.052 Million Avg 30-day Volume935.11 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.92716 52-week High/Low33.09 / 8.98 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TVTX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 2 (0.12%) 1 (0.06%) 100.0%
Funds Holding: 133 132 0.76% 50 (3.02%) 50 (3.11%) 0.0%
13F shares: 52.199 Million 51.975 Million 0.43% 26.115 Million 24.644 Million 5.97%
% Ownership 51.1539 48.2734 5.97%
New Positions: 26 15 73.33% 9 7 28.57%
Increased Positions 48 43 11.63% 18 12 50.0%
Closed Positions 22 28 -21.43% 8 12 -33.33%
Reduced Positions 39 49 -20.41% 19 26 -26.92%
Total Calls 127.118 Thousand 120.783 Thousand 5.24% 5.9 Thousand 14.1 Thousand -58.16%
Total Puts 150.885 Thousand 67.209 Thousand 124.5% 56.5 Thousand 0
PUT/CALL Ratio 1.19 0.56 112.5% 9.58 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Travere Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding TVTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TVTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

100.1 Thousand total shares from 40 transactions

Exercise Derivative Conversion (M)

25 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D

  • Officer
 34,832 2021-02-17 13

CLAGUE LAURA CHIEF FINANCIAL OFFICER

  • Officer
 32,223 2021-02-05 13

REED ELIZABETH E SVP, GC & CORPORATE SECRETARY

  • Officer
 37,705 2021-02-05 13

ROSENBERG NOAH L. CHIEF MEDICAL OFFICER

  • Officer
 46,344 2021-02-05 10

DUBE ERIC M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 156,813 2021-02-05 8

HEERMA PETER CHIEF COMMERCIAL OFFICER

  • Officer
 59,344 2021-02-05 5

ASELAGE STEVE

  • Director
 196,667 2021-02-02 10

LYONS GARY A

  • Director
 34,000 2020-05-15 1

MECKLER JEFFREY A

  • Director
 64,000 2020-05-15 1

COUGHLIN TIMOTHY

  • Director
 32,000 2020-05-15 1

BAYNES ROY D.

  • Director
 14,000 2020-05-15 1

ORWIN JOHN A

  • Director
 11,875 2020-05-15 1

SQUARER RON

  • Director
 11,875 2020-05-15 1

POOLE SANDRA

  • Director
 6,500 2020-05-15 1

BRUHN SUZANNE LOUISE

  • Director
 0 2020-04-08 2

MCFARLANE NEIL F. CHIEF OPERATING OFFICER

  • Officer
 26,988 2019-05-15 0

KOZARICH JOHN W

  • Director
 29,000 2019-05-08 0

SHIH ALVIN EVP OF RESEARCH & DEVELOPMENT

  • Officer
 158,334 2016-09-01 0

GOLDING CORNELIUS E

  • Director
 29,000 2016-05-18 0

VALEUR JENSEN MARGARET E GENERAL COUNSEL

  • Officer
 100,000 2016-02-01 0

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • 10% Owner
 2,658,854 2015-01-13 0

PLOTKIN HORACIO CHIEF MEDICAL OFFICER

  • Officer
 91,767 2014-12-12 0

RICHARDSON STEVEN GARY

  • Director
 129,165 2014-11-21 0

SHKRELI MARTIN

  • FMR OFFICER DIR 10% SHAREHLDR
 No longer subject to file 2014-11-14 0

PALEY JEFFREY

  • Director
 51,665 2014-08-14 0

PANOFF MARC L CHIEF FINANCIAL OFFICER

  • Officer
 221,100 2014-02-24 0

OPALEYE GP LLC

  • 10% Owner
 2,097,671 2013-12-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ASELAGE STEVE - Director

2021-02-02 21:18:32 -0500 2021-02-21 M 25,000 d 275,000 direct

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-18 18:26:09 -0500 2021-02-18 S 1,250 $28.67 d 34,832 direct yes

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-18 18:26:09 -0500 2021-02-17 S 1,250 $27.35 d 36,082 direct yes

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-09 16:30:57 -0500 2021-02-08 S 2,250 $31.58 d 37,332 direct yes

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-02-09 16:29:15 -0500 2021-02-08 S 2,250 $31.58 d 32,223 direct yes

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-02-09 16:31:39 -0500 2021-02-08 S 1,125 $31.58 d 59,344 direct yes

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-02-09 16:30:05 -0500 2021-02-08 S 2,250 $31.58 d 37,705 direct yes

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-02-09 16:32:38 -0500 2021-02-08 S 1,125 $31.58 d 46,344 direct yes

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-09 16:28:27 -0500 2021-02-08 S 4,813 $31.58 d 156,813 direct yes

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-02-09 16:32:38 -0500 2021-02-05 S 1,125 $31.41 d 47,469 direct yes

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-09 16:28:27 -0500 2021-02-05 S 4,813 $31.41 d 161,626 direct yes

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-09 16:30:57 -0500 2021-02-05 S 2,250 $31.41 d 39,582 direct yes

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-02-09 16:29:15 -0500 2021-02-05 S 2,250 $31.41 d 34,473 direct yes

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-02-09 16:31:39 -0500 2021-02-05 S 1,125 $31.41 d 60,469 direct yes

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-02-09 16:30:05 -0500 2021-02-05 S 2,250 $31.41 d 39,955 direct yes

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-02-05 16:48:32 -0500 2021-02-03 A 4,500 a 61,594 direct

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-02-05 16:47:35 -0500 2021-02-03 A 4,500 a 42,205 direct

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-02-03 21:33:24 -0500 2021-02-03 S 563 $28.91 d 44,094 direct yes

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-03 21:32:29 -0500 2021-02-03 S 2,500 $28.91 d 38,457 direct yes

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-02-03 21:30:47 -0500 2021-02-03 S 2,500 $28.91 d 33,348 direct yes

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-05 16:49:21 -0500 2021-02-03 A 4,500 a 41,832 direct

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-05 16:46:03 -0500 2021-02-03 A 17,500 a 166,439 direct

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-02-03 21:33:59 -0500 2021-02-03 S 563 $28.91 d 57,094 direct yes

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-02-03 21:33:24 -0500 2021-02-03 S 1,250 $28.91 d 44,657 direct yes

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-03 21:29:56 -0500 2021-02-03 S 2,406 $28.91 d 148,939 direct yes

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-02-03 21:31:37 -0500 2021-02-03 S 675 $28.91 d 37,705 direct yes

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-02-05 16:49:58 -0500 2021-02-03 A 4,500 a 48,594 direct

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-02-05 16:46:51 -0500 2021-02-03 A 4,500 a 36,723 direct

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-03 21:32:29 -0500 2021-02-03 S 1,125 $28.91 d 37,332 direct yes

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-02-03 21:30:47 -0500 2021-02-03 S 1,125 $28.91 d 32,223 direct yes

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-02-03 21:31:37 -0500 2021-02-03 S 2,500 $28.91 d 38,380 direct yes

ASELAGE STEVE - Director

2021-02-02 21:18:32 -0500 2021-02-02 M 25,000 $10.09 a 221,667 direct

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-02-02 21:19:22 -0500 2021-02-02 S 1,125 $30.75 d 35,848 direct yes

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-02 21:20:19 -0500 2021-02-02 S 2,406 $30.75 d 151,345 direct yes

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-02 21:23:10 -0500 2021-02-02 S 1,125 $30.75 d 43,457 direct yes

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-02-02 21:31:24 -0500 2021-02-02 S 563 $30.75 d 45,907 direct yes

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-02-02 21:21:05 -0500 2021-02-02 S 675 $30.75 d 40,880 direct yes

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-02-02 21:19:22 -0500 2021-02-02 S 2,500 $30.75 d 36,973 direct yes

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-02 21:20:19 -0500 2021-02-02 S 6,328 $29.60 d 153,751 direct

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-02 21:23:10 -0500 2021-02-02 S 2,500 $30.75 d 40,957 direct yes

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-02-02 21:31:24 -0500 2021-02-02 S 1,250 $30.75 d 46,470 direct yes

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-02-02 21:21:05 -0500 2021-02-02 S 2,500 $30.75 d 41,555 direct yes

ASELAGE STEVE - Director

2021-02-02 21:18:32 -0500 2021-02-02 S 25,000 $30.75 d 196,667 direct yes

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-02-03 21:33:59 -0500 2021-02-02 S 563 $30.75 d 57,657 direct yes

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-02-02 21:19:22 -0500 2021-01-31 A 5,000 a 39,473 direct

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-02 21:20:19 -0500 2021-01-31 A 15,000 a 160,079 direct

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-02-02 21:23:10 -0500 2021-01-31 A 5,000 a 44,582 direct

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-02-02 21:31:24 -0500 2021-01-31 A 5,000 a 47,720 direct

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-02-02 21:21:05 -0500 2021-01-31 A 5,000 a 44,055 direct

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-01-25 20:58:19 -0500 2021-01-21 A 15,000 a 39,582 direct -8.4662 9.3014 9.3014 6 -8.4662 2

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-01-25 20:55:57 -0500 2021-01-21 A 57,500 a 57,500 direct

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-25 20:54:29 -0500 2021-01-21 A 57,260 a 145,079 direct -8.4662 9.3014 9.3014 6 -8.4662 2

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-01-25 20:56:43 -0500 2021-01-21 A 57,500 a 57,500 direct

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-28 20:00:11 -0500 2021-01-21 A 212,660 a 212,660 direct

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-01-25 20:57:30 -0500 2021-01-21 A 57,500 a 57,500 direct

HEERMA PETER - Officer CHIEF COMMERCIAL OFFICER

2021-01-25 20:55:57 -0500 2021-01-21 A 15,000 a 58,220 direct -8.4662 9.3014 9.3014 6 -8.4662 2

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-01-25 20:55:14 -0500 2021-01-21 A 57,500 a 57,500 direct

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-01-25 20:56:43 -0500 2021-01-21 A 15,000 a 39,055 direct -8.4662 9.3014 9.3014 6 -8.4662 2

ROTE WILLIAM E. - Officer SENIOR VICE PRESIDENT, R&D

2021-01-25 20:58:19 -0500 2021-01-21 A 57,500 a 57,500 direct

ROSENBERG NOAH L. - Officer CHIEF MEDICAL OFFICER

2021-01-25 20:57:30 -0500 2021-01-21 A 15,000 a 42,720 direct -8.4662 9.3014 9.3014 6 -8.4662 2

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-25 20:54:29 -0500 2021-01-21 A 212,600 a 212,600 direct

CLAGUE LAURA - Officer CHIEF FINANCIAL OFFICER

2021-01-25 20:55:14 -0500 2021-01-21 A 15,000 a 34,473 direct -8.4662 9.3014 9.3014 6 -8.4662 2

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-07 18:29:31 -0500 2021-01-06 S 3,438 $27.01 d 87,819 direct yes 1.7043 2.7047 9.8926 17.7103 20 -10.6706 13

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-01-07 18:30:37 -0500 2021-01-06 S 688 $27.01 d 24,055 direct yes 1.7043 2.7047 9.8926 17.7103 20 -10.6706 13

DUBE ERIC M - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-07 18:29:31 -0500 2021-01-05 S 3,438 $26.65 d 91,257 direct yes 1.7043 2.7047 9.8926 17.7103 20 -10.6706 13

REED ELIZABETH E - Officer SVP, GC & CORPORATE SECRETARY

2021-01-07 18:30:37 -0500 2021-01-05 S 688 $26.65 d 24,743 direct yes 1.7043 2.7047 9.8926 17.7103 20 -10.6706 13

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 20:45:03 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 20:15:03 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 19:45:03 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 19:15:02 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 18:45:03 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 18:15:04 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 17:45:02 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 17:15:03 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 16:45:03 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 16:15:04 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 15:45:03 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 15:15:03 UTC -0.3598 0.4298 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 14:45:03 UTC -0.18 0.25 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 14:15:03 UTC -0.18 0.25 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 13:45:03 UTC -0.18 0.25 750000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 13:15:04 UTC -0.18 0.25 700000
TRAVERE THERAPEUTICS INC TVTX 2021-03-03 12:45:03 UTC -0.18 0.25 350000
TRAVERE THERAPEUTICS INC TVTX 2021-03-02 22:15:02 UTC -0.18 0.25 700000
TRAVERE THERAPEUTICS INC TVTX 2021-03-02 21:45:03 UTC -0.18 0.25 700000
TRAVERE THERAPEUTICS INC TVTX 2021-03-02 21:15:03 UTC -0.18 0.25 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund TVTX -53137.0 shares, $-1075492.88 2020-10-31 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND TVTX -22600.0 shares, $-615963.0 2020-12-31 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund TVTX -4909.0 shares, $-99358.16 2020-10-30 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund TVTX -9461.0 shares, $-257859.56 2020-12-31 N-PORT

Elevate your investments